Definition
Bradykinin is a nonapeptide that is mainly found in animal preparations that are treated with the venom of the snake, Bothrops jararaca1,2. It dialates blood vessels that in turn leads to decrease in blood pressure2. Bradykinin analogs are slightly modified structural derivatives of bradykinin that perform similar functions as bradykinin3.
Discovery
Bradykinin was discovered in the blood plasma of animals that were treated with the venom from the Brazilian snake, Bothrops jararaca1,2. The discovery was part of a study that was related to toxicology of snake bites. Bradykinin analogs were synthesized by solid-phase techniques in 1975 and their function was studied in rats and rabbits3.
Classification
Bradykinin is a 9 amino acid peptide that belongs to the kinin family of proteins4. It has homologs in several animals including other snakes, frog, dog and humans4.
Structural Characteristics
Bradykinin has the sequence Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg3. Several analogs of bradykinin have been synthesized. They are also nanopeptides containing substitutions of various amino acids of bradykinin. For example two analogs of bradykinin were synthesized one with 7-beta-homo-L-proline and the other with 8-beta-homo-L-phenylalanine substitutions3. It was found that both of them are resistant to enzymatic degradation3.
Mode of action
Bradykinin binds to two different kinin G protein coupled receptors- B1 and B25. Upon binding to these receptors it induces conversion of GTP to GDP which in turn triggers the conversion ATP to cAM which then acts as a second messanger resulting in the activation of genes. B1 receptor is expressed as a result of tissue injury and is found to play a role in inflammation while B2 receptor participates in the vasodilatory role of bradykinin5,6. Bradykinin analogs function is a similar fashion although depending on their structure they might have varying affinities to the receptors compared to bradykinin7. Also analogs of bradykinin have been synthesized that are specific to one of these receptors7.
Functions
Bradykinin is a potent endothelium-dependent vasodilator, causes contraction of non-vascular smooth muscle, increases vascular permeability and also is involved in the mechanism of pain. Bradykinin also causes natriuresis, contributing to a drop in blood pressure8. Bradykinin raises internal calcium levels in neocortical astrocytes causing them to release glutamate9. Overactivation of bradykinin is thought to play a role in a rare disease called Hereditary Angioedema, also known as Hereditary Angio-Neurotic Edema10.
Some analogs of bradykinin have been found to have prolonged hypotensive action compared to bradykinin (Eg: beta-H-Pro-bradykinin)3. Some analogs have relative or even lower potencies compared to bradykinin (Eg: HArg1-Bradykinin and HArg9 Bradykinin)7. Other analogs have been studied for their potential of finding bradykinin antagonists that might be useful in the treatment of angio-neurotic edema.
References
1.Partridge, SM (1948). (Title or abstract not available), Biochem. J., 42, 238.
2.Allen PK, Kusumam J, Yoji S, Yoshitaka N, Berhane G, Sesha R and Michael S (1998). Bradykinin formation: Plasma and tissue pathways and cellular interactions. Clinical reviews in allergy and immunology, 16, 4, 403-429.
3.Ondetti MA, Engel SL (1975). Bradykinin analogs containing beta.-homoamino acid, J. Med. Chem.,18 (7), 761–763.
4.Roseli A, Gomes S, Jair RC, Luis J and Valdemar H (1996). Met-Lys-Bradykinin-Ser, the kinin released from human kininogen by human pepsin. Immunopharmacology, 32, 76-79.
5.Peter GM, Amrita A, and Mauro P (2000). Association between Kinin B1 Receptor Expression and Leukocyte Trafficking across Mouse Mesenteric Postcapillary Venules. J Exp. Med., 192, 367-380.
6.Duchene J, Lecomte F, Ahmed S, Cayla C, Pesquero J, Bader M, Perretti M and Ahluwalia A, (2007). A Novel Inflammatory Pathway Involved in Leukocyte Recruitment: Role for the Kinin B1 Receptor and the Chemokine CXCL5. J Immunol., 179, 4849-4856.
7.Max ES, Phyllis AL (1974). Synthesis and pharmacology of homoarginine bradykinin analog. J. Med. Chem., 17 (11), pp 1227–1228.
8.Dendorfer A, Wolfrum S, Wagemann M, Qadri F, Dominiak P, (2001). Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats. Am J Physiol Heart Circ Physiol., 280:H2182
9.Kuoppala A, Lindstedt KA, Saarinen J, Kovanen PT, Kokkonen JO (2000). Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma. Am J Physiol Heart Circ Physiol, 278(4):H1069-74.
10.Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G (2007). Nonallergic angioedema: role of bradykinin. Allergy, 62(8):842-56.
Thursday, June 25, 2009
Bradykinin-Potentiating Peptides (BPP)
Definition
Bradykinin potentiating peptides (BPPs) isolated from the venom of the snake, Bothrops jararaca increase both the duration and magnitude of bradykinin’s (Nonapeptide found in the blood plasma of animals after injection of venom) effects on vasodilation and the consequent fall in blood pressure1.
Discovery
BPPs were discovered in partially purified preparations of Bothrops jararaca venom by their ability to increase bradykinin activity in vitro in guinea pig ileum and in vivo in rats1.
Classification
BPPs are naturally occurring inhibitors of angiotensin-converting enzyme (ACE) 2. They present a classic motif and can be recognized by their pyroglutamyl rich sequences2.
Structural Characteristics
BPPs are short 5-13 amino acid peptides with a proline rich sequence3. They have a cyclised form of glutamic acid as their N-terminus. For example, the structure of an active BPP pentapeptide is pyrrolidone-carboxyl-Lys-Trp-Ala-Pro3.
Mode of action
BPPs potentiate bradykinin activity primarily by blocking the function of kininase enzymes which are inhibitors of bradykinin4. They are also known to increase bradykinin’s affinity to its receptors by promoting their sensitization4.
Functions
The chemical and pharmacological properties of BPPs were used for the development of captopril, the first active site directed inhibitor of ACE, currently used to treat human hypertension5. BPPs increase bradykinin activity in non-vascular smooth muscle contraction, vasodilation and lowering of blood pressure6.
References
1. Ferreira, SH (1965). Bradykinin-potentiating factor (BPF) present in venom of Bothropsjararaca. Br. J. Pharmac. Chemother., 24, 163-169.
2.Katia C, Katsuhiro K, Robson Lopes DM, Marta MA, Carlos J, Juliana MS, Isaltino MC, Benedito CP, Antônio CMDC and Daniel CP (2006). Isolation and characterization of a novel bradykinin potentiating peptide (BPP) from the skin secretion of Phyllomedusa hypochondrialis. Peptides, 28, 3, 515-523.
3.Lewis JG, Sergio HF and John MS (1971). Bradykinin Potentiating Factor. Chest, 59;9S-10S.
4.Camargo A and Ferreira SH (1971). Action of bradykinin potentiating factor (BPF) and dimercaprol (BAL) on the responses to bradykinin of isolated preparations of rat intestines. Br J Pharmacol., 42(2): 305–307.
5.Fernandez JH, Neshich G and Camargo ACM (2004). Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs. Genet. Mol. Res., 3 (4): 554-563.
6.Mueller S, Gothe R, Siems WD, Vietinghoff G, Paegelow I, Reissmann S (2005). Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9 alpha. Peptides, 26(7):1235-47.
Bradykinin potentiating peptides (BPPs) isolated from the venom of the snake, Bothrops jararaca increase both the duration and magnitude of bradykinin’s (Nonapeptide found in the blood plasma of animals after injection of venom) effects on vasodilation and the consequent fall in blood pressure1.
Discovery
BPPs were discovered in partially purified preparations of Bothrops jararaca venom by their ability to increase bradykinin activity in vitro in guinea pig ileum and in vivo in rats1.
Classification
BPPs are naturally occurring inhibitors of angiotensin-converting enzyme (ACE) 2. They present a classic motif and can be recognized by their pyroglutamyl rich sequences2.
Structural Characteristics
BPPs are short 5-13 amino acid peptides with a proline rich sequence3. They have a cyclised form of glutamic acid as their N-terminus. For example, the structure of an active BPP pentapeptide is pyrrolidone-carboxyl-Lys-Trp-Ala-Pro3.
Mode of action
BPPs potentiate bradykinin activity primarily by blocking the function of kininase enzymes which are inhibitors of bradykinin4. They are also known to increase bradykinin’s affinity to its receptors by promoting their sensitization4.
Functions
The chemical and pharmacological properties of BPPs were used for the development of captopril, the first active site directed inhibitor of ACE, currently used to treat human hypertension5. BPPs increase bradykinin activity in non-vascular smooth muscle contraction, vasodilation and lowering of blood pressure6.
References
1. Ferreira, SH (1965). Bradykinin-potentiating factor (BPF) present in venom of Bothropsjararaca. Br. J. Pharmac. Chemother., 24, 163-169.
2.Katia C, Katsuhiro K, Robson Lopes DM, Marta MA, Carlos J, Juliana MS, Isaltino MC, Benedito CP, Antônio CMDC and Daniel CP (2006). Isolation and characterization of a novel bradykinin potentiating peptide (BPP) from the skin secretion of Phyllomedusa hypochondrialis. Peptides, 28, 3, 515-523.
3.Lewis JG, Sergio HF and John MS (1971). Bradykinin Potentiating Factor. Chest, 59;9S-10S.
4.Camargo A and Ferreira SH (1971). Action of bradykinin potentiating factor (BPF) and dimercaprol (BAL) on the responses to bradykinin of isolated preparations of rat intestines. Br J Pharmacol., 42(2): 305–307.
5.Fernandez JH, Neshich G and Camargo ACM (2004). Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs. Genet. Mol. Res., 3 (4): 554-563.
6.Mueller S, Gothe R, Siems WD, Vietinghoff G, Paegelow I, Reissmann S (2005). Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9 alpha. Peptides, 26(7):1235-47.
Wednesday, June 17, 2009
Bacterial Peptides
Definition
Bacterial peptides are protein fragments which are either part of a bacterium or produced by a bacteria1.
Classification
Different classes of peptides are produced by bacteria. Some examples include, antibiotics, enterotoxins, flagellar proteins, lipoproteins and various enzymes1.
Structural Characteristics
Structural characteristics of some bacterial peptides are described below-
A)Malaria merozoite surface peptide (MSP-1): It is synthesized as a large precursor on the surface of the bacterium Plasmodium falciparum. Proteolytic cleavage results in the production of a 19 KDa product whose tertiary structure is maintained by disulphide bridges2.
B)Giardia variable surface protein: This peptide is the specific conserved region of the Giardia variable surface proteins (VSPs) that are cysteine rich zinc finger proteins. VSPs differ in size and sequence, they are characterized by this highly conserved C-terminal membrane spanning region, a hydrophilic cytoplasmic tail with a conserved five amino acid CRGKA signature sequence3,4.
C)P.falciparum liver stage antigen 3: The protein is 200Kda and is highly conserved among parasites from different geographic regions5.
Mode of action
A)MSP-1 is known to trigger antibody response by CD4 helper T cells. It is likely that these cells bind to the C-terminal domain of MSP-12.
B)VSPs have a conserved hydrophilic amono acid trail that is palmitoyted by palmityl tranferases upon which they are activated3,4.
C)P. falciparum liver stage antigen 3 is a potent antigen that is recongnized by T cells5.
Functions
A)MSP-1 is a vaccine candidate for Plasmodium falciparum infection. It triggers a CD-4 T cell response2.
B)VSPs are necessary for survival in the environment and host infection3,4.
C)P.falciparum stage antigen 3 is also a good candidate vaccine as it activates both T and B cell responses5.
Bacterial peptides are protein fragments which are either part of a bacterium or produced by a bacteria1.
Classification
Different classes of peptides are produced by bacteria. Some examples include, antibiotics, enterotoxins, flagellar proteins, lipoproteins and various enzymes1.
Structural Characteristics
Structural characteristics of some bacterial peptides are described below-
A)Malaria merozoite surface peptide (MSP-1): It is synthesized as a large precursor on the surface of the bacterium Plasmodium falciparum. Proteolytic cleavage results in the production of a 19 KDa product whose tertiary structure is maintained by disulphide bridges2.
B)Giardia variable surface protein: This peptide is the specific conserved region of the Giardia variable surface proteins (VSPs) that are cysteine rich zinc finger proteins. VSPs differ in size and sequence, they are characterized by this highly conserved C-terminal membrane spanning region, a hydrophilic cytoplasmic tail with a conserved five amino acid CRGKA signature sequence3,4.
C)P.falciparum liver stage antigen 3: The protein is 200Kda and is highly conserved among parasites from different geographic regions5.
Mode of action
A)MSP-1 is known to trigger antibody response by CD4 helper T cells. It is likely that these cells bind to the C-terminal domain of MSP-12.
B)VSPs have a conserved hydrophilic amono acid trail that is palmitoyted by palmityl tranferases upon which they are activated3,4.
C)P. falciparum liver stage antigen 3 is a potent antigen that is recongnized by T cells5.
Functions
A)MSP-1 is a vaccine candidate for Plasmodium falciparum infection. It triggers a CD-4 T cell response2.
B)VSPs are necessary for survival in the environment and host infection3,4.
C)P.falciparum stage antigen 3 is also a good candidate vaccine as it activates both T and B cell responses5.
Protein post-translational modifications
Post-translational modifications are the chemical modifications of proteins subsequent to their biosynthesis. The modification of certain amino acid residues may result in changes of the protein conformation and/or its capacity to interact with other proteins or ligands, to be active or inactive in the case of an enzyme, to allow or interfere with gene expression and many other biological functions. These modifications have been found by using radioactively labeled compounds, to yield a protein(s) carrying a radioactive tag located in the modifying group and that can be detected by methods such as autoradiography, liquid scintillation, and other methods after resolution of the different compounds by electrophoresis, chromatography and other separation procedures.
Confirmation of the modification is carried out by chemical synthesis of the modified amino acid and its structural confirmation by mass spectra. Once the nature of the modification has been establish, the most straightforward method of detecting it is by the use of specific antibodies against the chemical modification. Use of tagged antibodies would allow to detect the distribution of the modification in tissues by using histochemical methods and its evaluation by immune assays such as ELISA.
Although there are many post-translational modifications, some have shown to be crucial for several biological functions, such as:
·Phosphorylation or the addition of a phosphate group to tyrosine, serine, threonine or histidine. This modification affects the activity of certain oncoproteins, eg. Her and EGF.
·Acylation or the addition of an acetyl group to the lysine residues of a protein and/or its terminal amino group. This modification happens usually in histones and regulates the expression of certain genes in a mechanism know as epigenetic effects.
·Prenylation is the addition of a prenyl groups that are hydrophobic to the C-terminal cysteine residues of a protein. It occurs in several oncoprotein and the most common prenyl groups are farnesyl and geranyl-geranyl groups.
·Glycation is the addition of reducing sugar to a lysine amino group via a Schiff base. This modification plays an important role in diabetes.
·ADP-ribosylation is a modification in which ADP-ribose moieties are incorporated the arginine, glutamic or aspartic acid residues of a protein. This modification is involved in signaling and control processes such as DNA repair and apoptosis.
·Post-translational modifications also involve conjugation of a protein to other proteins or peptides, such as ubiquitylation or linkage to the protein ubiquitin. This modification tags an obsolete protein for degradation by the proteosomes.
Other modifications include the formation and cleavage of disulfide bonds, deamination of glutamine, asparagine and arginine. Modifications that contribute to changes in the structural properties of a protein.
An important post-translational modification is the proteolytic cleavage of the lipophilic amino acid sequence in some protein precursors, which is needed to translocate the protein across the lipid bilayer of cellular membranes.
Glycosylation of proteins to yield glycoproteins is a modification that plays an important role in the movement and recognition of cells from the immune system. Glycosylation also have a role in differentiation as well as cancer metastasis. Addition of the sugar residues, take place at the asparagine, serine ot threonine amino acids.
In addition, there are some post-translational modifications that are introduce into purified proteins, such as pegylation, to limit the immunogenicity of a protein. Free amino groups from proteins can be converted to carboxylic grops by succinylation, a modification that changes a cationic protein to an anionic one.
As mentioned before, the use of specific antibodies to these modifications is the easiest way to detect and follow them. BioSynthesis monospecific antibodies are prepared using our own modified antigens and using proprietary immunostimulants to obtain high affinity antibodies. These antibodies can be supply as antisera or as purified antibodies and their conjugates with fluorescent tags and enzymes.
Confirmation of the modification is carried out by chemical synthesis of the modified amino acid and its structural confirmation by mass spectra. Once the nature of the modification has been establish, the most straightforward method of detecting it is by the use of specific antibodies against the chemical modification. Use of tagged antibodies would allow to detect the distribution of the modification in tissues by using histochemical methods and its evaluation by immune assays such as ELISA.
Although there are many post-translational modifications, some have shown to be crucial for several biological functions, such as:
·Phosphorylation or the addition of a phosphate group to tyrosine, serine, threonine or histidine. This modification affects the activity of certain oncoproteins, eg. Her and EGF.
·Acylation or the addition of an acetyl group to the lysine residues of a protein and/or its terminal amino group. This modification happens usually in histones and regulates the expression of certain genes in a mechanism know as epigenetic effects.
·Prenylation is the addition of a prenyl groups that are hydrophobic to the C-terminal cysteine residues of a protein. It occurs in several oncoprotein and the most common prenyl groups are farnesyl and geranyl-geranyl groups.
·Glycation is the addition of reducing sugar to a lysine amino group via a Schiff base. This modification plays an important role in diabetes.
·ADP-ribosylation is a modification in which ADP-ribose moieties are incorporated the arginine, glutamic or aspartic acid residues of a protein. This modification is involved in signaling and control processes such as DNA repair and apoptosis.
·Post-translational modifications also involve conjugation of a protein to other proteins or peptides, such as ubiquitylation or linkage to the protein ubiquitin. This modification tags an obsolete protein for degradation by the proteosomes.
Other modifications include the formation and cleavage of disulfide bonds, deamination of glutamine, asparagine and arginine. Modifications that contribute to changes in the structural properties of a protein.
An important post-translational modification is the proteolytic cleavage of the lipophilic amino acid sequence in some protein precursors, which is needed to translocate the protein across the lipid bilayer of cellular membranes.
Glycosylation of proteins to yield glycoproteins is a modification that plays an important role in the movement and recognition of cells from the immune system. Glycosylation also have a role in differentiation as well as cancer metastasis. Addition of the sugar residues, take place at the asparagine, serine ot threonine amino acids.
In addition, there are some post-translational modifications that are introduce into purified proteins, such as pegylation, to limit the immunogenicity of a protein. Free amino groups from proteins can be converted to carboxylic grops by succinylation, a modification that changes a cationic protein to an anionic one.
As mentioned before, the use of specific antibodies to these modifications is the easiest way to detect and follow them. BioSynthesis monospecific antibodies are prepared using our own modified antigens and using proprietary immunostimulants to obtain high affinity antibodies. These antibodies can be supply as antisera or as purified antibodies and their conjugates with fluorescent tags and enzymes.
ATPase
Definition
ATPases are a class of enzymes that catalyze the decomposition of adenosine triphosphate (ATP) into adenosine diphosphate (ADP) and a free phosphate ion.
Discovery
Na+/K+-ATPase was discovered by Danish biologist Jens Christian Skou in 19571.
Classification
There are different types of ATPases which differs in their functions, structure and in the type of ions they transport viz., F-ATPases, V-ATPases, A-ATPases, P-ATPases and E-ATPases. F-ATPases are found in mitochondria, chloroplasts and bacterial plasma membranes produce ATP, using the proton gradient generated by oxidative phosphorylation (mitochondria) or photosynthesis (chloroplasts). V-ATPases are found in eukaryotic vacuoles, catalyzing ATP hydrolysis to transport solutes and lower pH in organelles. A-ATPases are found in Archaea and their functionality is similar to F-ATPases. P-ATPases are found in bacteria, fungi and in eukaryotic plasma membranes and organelles, and function to transport a variety of different ions across membranes. E-ATPases are cell-surface enzymes that hydrolyse a range of NTPs, viz., extracellular ATP.
Structural characteristics
ATPases are integral membrane proteins and move solutes across the membrane. Na+-K+-ATPase is composed of two subunits. The alpha subunit (~113 kDa) binds ATP and both sodium and potassium ions, and contains the phosphorylation site. The smaller beta subunit (~35 kDa glycoprotein) is necessary for activity of the complex. It appears to be critical in facilitating the plasma membrane localization and activation of the alpha subunit2.
Mode of action
The sodium-potassium exchanger (Na+/K+ATPase) enzymatic activity is initiated by binding to ATP and three intracellular Na+ ions. ATP is hydrolyzed, leading to phosphorylation of a cytoplasmic loop of the pump and release of ADP. A conformational change in the pump exposes the Na+ ions to the outside, where they are released. The pump binds two extracellular K+ ions, leading to dephosphorylation of the alpha subunit. ATP binds and the pump reorients to release K+ ions inside the cell, which results in electrical gradient across the cell membrane.
Functions
ATPases import many of the metabolites like glucose, amino acids and other nutrients into the cell necessary for cell metabolism and export toxins, wastes, and other solutes that can hinder cellular processes. The ionic transport conducted by sodium pumps (Na+/K+ATPase) creates both an electrical and chemical gradient across the plasma membrane. It helps in electrolyte movement across epithelial cells. The cell's resting membrane potential is a manifestation of the electrical gradient, and the gradient is the basis for excitability in nerve and muscle cells. The hydrogen potassium ATPase (H+/K+ATPase or gastric proton pump) acidifies the contents in the stomach3.
References
1.Boldyrev AA (2000). Na+,K+-ATPase: 40 years of investigations. Membr Cell Biol., 13(6):715-719.
2.Lingrel JB, Kuntzweiler T (1994). Na+, K+-ATPase. J Biol Chem., 269:19659.
3.Schubert, Mitchell L (2007). Gastric secretion. Current Opinion in Gastroenterology., 23(6) 595-601.
ATPases are a class of enzymes that catalyze the decomposition of adenosine triphosphate (ATP) into adenosine diphosphate (ADP) and a free phosphate ion.
Discovery
Na+/K+-ATPase was discovered by Danish biologist Jens Christian Skou in 19571.
Classification
There are different types of ATPases which differs in their functions, structure and in the type of ions they transport viz., F-ATPases, V-ATPases, A-ATPases, P-ATPases and E-ATPases. F-ATPases are found in mitochondria, chloroplasts and bacterial plasma membranes produce ATP, using the proton gradient generated by oxidative phosphorylation (mitochondria) or photosynthesis (chloroplasts). V-ATPases are found in eukaryotic vacuoles, catalyzing ATP hydrolysis to transport solutes and lower pH in organelles. A-ATPases are found in Archaea and their functionality is similar to F-ATPases. P-ATPases are found in bacteria, fungi and in eukaryotic plasma membranes and organelles, and function to transport a variety of different ions across membranes. E-ATPases are cell-surface enzymes that hydrolyse a range of NTPs, viz., extracellular ATP.
Structural characteristics
ATPases are integral membrane proteins and move solutes across the membrane. Na+-K+-ATPase is composed of two subunits. The alpha subunit (~113 kDa) binds ATP and both sodium and potassium ions, and contains the phosphorylation site. The smaller beta subunit (~35 kDa glycoprotein) is necessary for activity of the complex. It appears to be critical in facilitating the plasma membrane localization and activation of the alpha subunit2.
Mode of action
The sodium-potassium exchanger (Na+/K+ATPase) enzymatic activity is initiated by binding to ATP and three intracellular Na+ ions. ATP is hydrolyzed, leading to phosphorylation of a cytoplasmic loop of the pump and release of ADP. A conformational change in the pump exposes the Na+ ions to the outside, where they are released. The pump binds two extracellular K+ ions, leading to dephosphorylation of the alpha subunit. ATP binds and the pump reorients to release K+ ions inside the cell, which results in electrical gradient across the cell membrane.
Functions
ATPases import many of the metabolites like glucose, amino acids and other nutrients into the cell necessary for cell metabolism and export toxins, wastes, and other solutes that can hinder cellular processes. The ionic transport conducted by sodium pumps (Na+/K+ATPase) creates both an electrical and chemical gradient across the plasma membrane. It helps in electrolyte movement across epithelial cells. The cell's resting membrane potential is a manifestation of the electrical gradient, and the gradient is the basis for excitability in nerve and muscle cells. The hydrogen potassium ATPase (H+/K+ATPase or gastric proton pump) acidifies the contents in the stomach3.
References
1.Boldyrev AA (2000). Na+,K+-ATPase: 40 years of investigations. Membr Cell Biol., 13(6):715-719.
2.Lingrel JB, Kuntzweiler T (1994). Na+, K+-ATPase. J Biol Chem., 269:19659.
3.Schubert, Mitchell L (2007). Gastric secretion. Current Opinion in Gastroenterology., 23(6) 595-601.
Annexin
Definition
Annexins are calcium-dependent phospholipid-binding proteins. More than a thousand proteins of the annexin superfamily have been identified in major eukaryotic phyla, but annexins are absent from yeasts and prokaryotes.
Discovery
The first annexin to be identified was annexin VII (synexin) from the bovine adrenal medulla by creutz and team in 19781.
Classification
Annexins are grouped under 5 major classes (A-E), the 12 annexins which are commonly found in vertebrates are classified under annexin A family and named as annexins A1-A13 (or ANXA1-ANXA13), leaving A12 not assigned in the official nomenclature. Annexins outside vertebrates are classified under family B (in invertebrates), C (in fungi and under groups of unicellular eukaryotes), D (in plants), and E (in protists).
Structural Characteristics
Each annexin is composed of two principal domains: the divergent NH2-terminal “head” and the conserved COOH-terminal protein core. The COOH-terminal protein core harbors the Ca2+ and membrane binding sites and is responsible for mediating the canonical membrane binding properties. An annexin core comprises four (in annexin A6 eight) segments of internal and interannexin homology that are easily identified in a linear sequence alignment. It forms a highly alpha helical and tightly packed disk with a slight curvature and two principle sides. The more convex side contains Ca2+ binding sites, the so-called type II and type III sites, and faces the membrane when an annexin is associated peripherally with phospholipids2. Many annexins undergo posttranslational modifications viz., phosphorylation and myristoylation1.
Mode of action
The process of membrane aggreagation requires the self association of annexin molecules where Ca2+ plays an important role. In case of synexin (annexin VII) at lower concentration of Ca2+ level it is soluble, if the concentration of Ca2+ increase it results in binding of annexins to membrane further increase in Ca2+ levels results in membrane aggregation and fusion.
Function
Annexins interact with various cell-membrane components that are involved in the structural organization of the cell, intracellular signaling by enzyme modulation and ion fluxes, growth control, and they can act as atypical calcium channels1.
References
1.Moss SE, Morgan RO (2004). The Annexins. Genome Biol., 5(4): 219.
Annexins are calcium-dependent phospholipid-binding proteins. More than a thousand proteins of the annexin superfamily have been identified in major eukaryotic phyla, but annexins are absent from yeasts and prokaryotes.
Discovery
The first annexin to be identified was annexin VII (synexin) from the bovine adrenal medulla by creutz and team in 19781.
Classification
Annexins are grouped under 5 major classes (A-E), the 12 annexins which are commonly found in vertebrates are classified under annexin A family and named as annexins A1-A13 (or ANXA1-ANXA13), leaving A12 not assigned in the official nomenclature. Annexins outside vertebrates are classified under family B (in invertebrates), C (in fungi and under groups of unicellular eukaryotes), D (in plants), and E (in protists).
Structural Characteristics
Each annexin is composed of two principal domains: the divergent NH2-terminal “head” and the conserved COOH-terminal protein core. The COOH-terminal protein core harbors the Ca2+ and membrane binding sites and is responsible for mediating the canonical membrane binding properties. An annexin core comprises four (in annexin A6 eight) segments of internal and interannexin homology that are easily identified in a linear sequence alignment. It forms a highly alpha helical and tightly packed disk with a slight curvature and two principle sides. The more convex side contains Ca2+ binding sites, the so-called type II and type III sites, and faces the membrane when an annexin is associated peripherally with phospholipids2. Many annexins undergo posttranslational modifications viz., phosphorylation and myristoylation1.
Mode of action
The process of membrane aggreagation requires the self association of annexin molecules where Ca2+ plays an important role. In case of synexin (annexin VII) at lower concentration of Ca2+ level it is soluble, if the concentration of Ca2+ increase it results in binding of annexins to membrane further increase in Ca2+ levels results in membrane aggregation and fusion.
Function
Annexins interact with various cell-membrane components that are involved in the structural organization of the cell, intracellular signaling by enzyme modulation and ion fluxes, growth control, and they can act as atypical calcium channels1.
References
1.Moss SE, Morgan RO (2004). The Annexins. Genome Biol., 5(4): 219.
Calcineurin (PP2B)
Definition
Calcineurin also known as protein phosphatase 2B (PP2B), is a phosphoprotein serine/threonine phosphatase, activated physiologically by Ca2+–calmodulin.
Discovery
It was identified and characterized by Claude Klee and Philip Cohen in the late 1970s.
Structural Characteristics
Calcineurin is a dimer of an A catalytic subunit and a B subunit. Calmodulin becomes tightly associated with calcineurin only in the presence of elevated, but physiological, levels of Ca2+ 1.
Classification
In mammals three isoforms of calcineurin A (Aa, Aß and A?) and two isoforms of calcineurin B (B1, and B2) are expressed from separate genes1.
Mode of action
In resting cells, nuclear factor of activated T-cells (NFAT) proteins are phosphorylated, and in cells exposed to stimuli that raise intracellular free Ca2+ levels, they are dephosphorylated by the calmodulin-dependent phosphatase calcineurin. On dephosphorylation NFAT translocate to the nucleus whereon, it binds to consensus DNA sites and controls gene transcription2.
Functions
Calcineurin plan an important role in intracellular signaling. In budding yeast, calcineurin has a role in coordinating adaptation to environmental stress both through the calcineurin–Crz1p transcriptional pathway and through post-translational mechanisms. Calcineurin signaling is involved in the long-term adaptation after chronic drug treatment in a way that may parallel its role during memory formation3.
References
1.Hogan PG, Li H (2005). Calcineurin. Curr Biol., 15(12):442-443.
2.Valerie Horsley and Grace K. Pavlath (2002). Nfat: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol., 156(5): 771–774.
3.Biala G (2007). Memory processes and addiction: involvement of the calcineurin signaling pathway. Postepy Hig Med Dosw (Online)., 61:199-203.
Calcineurin also known as protein phosphatase 2B (PP2B), is a phosphoprotein serine/threonine phosphatase, activated physiologically by Ca2+–calmodulin.
Discovery
It was identified and characterized by Claude Klee and Philip Cohen in the late 1970s.
Structural Characteristics
Calcineurin is a dimer of an A catalytic subunit and a B subunit. Calmodulin becomes tightly associated with calcineurin only in the presence of elevated, but physiological, levels of Ca2+ 1.
Classification
In mammals three isoforms of calcineurin A (Aa, Aß and A?) and two isoforms of calcineurin B (B1, and B2) are expressed from separate genes1.
Mode of action
In resting cells, nuclear factor of activated T-cells (NFAT) proteins are phosphorylated, and in cells exposed to stimuli that raise intracellular free Ca2+ levels, they are dephosphorylated by the calmodulin-dependent phosphatase calcineurin. On dephosphorylation NFAT translocate to the nucleus whereon, it binds to consensus DNA sites and controls gene transcription2.
Functions
Calcineurin plan an important role in intracellular signaling. In budding yeast, calcineurin has a role in coordinating adaptation to environmental stress both through the calcineurin–Crz1p transcriptional pathway and through post-translational mechanisms. Calcineurin signaling is involved in the long-term adaptation after chronic drug treatment in a way that may parallel its role during memory formation3.
References
1.Hogan PG, Li H (2005). Calcineurin. Curr Biol., 15(12):442-443.
2.Valerie Horsley and Grace K. Pavlath (2002). Nfat: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol., 156(5): 771–774.
3.Biala G (2007). Memory processes and addiction: involvement of the calcineurin signaling pathway. Postepy Hig Med Dosw (Online)., 61:199-203.
Bombesin and Analogs
Definition
Bombesin is a polypeptide that is found in the brain and gastrointestinal tract. Experimentally it has shown to cause the secretion of various substances (as gastrin and cholecystokinin) and to inhibit intestinal motility.
Discovery
Bombesin was isolated from the skin of the frog Bombina bonmina by Anastasi and team in 19711.
Classification
Bombesin-like peptides are grouped into three families - 1) Bombesin group, viz., bombesin and alytesin, 2) Ranatensin group viz., ranatensins, litorin, and Rohdei litorin, 3) Phyllolitorin group viz., Leu(8)- and Phe(8)-phyllolitorins.
Structural characteristics
Bombesin is a small peptide of 14 amino acids.
Mode of action
The biological activity of bombesin is mediated by binding to specific receptors viz., gastrin releasing peptide receptor (GRPR; called also BB2 receptor), neuromedin B receptor (NMBR; called also BB1 receptor) and bombesin receptor subtype 3 (BRS-3; called also BB3 receptor). Bombesin induce Ca2+ release from intracellular stores2.
Functions
Bombesin and bombesin-like factors show a wide spectrum of biological activities. It regulates the contraction of smooth muscle cells, induction of the secretion of neuropeptides and hormones. It is one of the most powerful substances showing anorexic effects in the hypothalamus. It induces the release of gastrin and cholecystokinin in the intestines and the pancreas. They also posses activities of cytokines.
References
1.Anastasi A, Erspamer V, Bucci M (1971). Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia., 27(2):166-167.
2. Wang JL, Kalyanaraman S, Vivo MD, Gautam N (1996). Bombesin and thrombin affect discrete pools of intracellular calcium through different G-proteins. Biochem J., 320:87-91.
Bombesin is a polypeptide that is found in the brain and gastrointestinal tract. Experimentally it has shown to cause the secretion of various substances (as gastrin and cholecystokinin) and to inhibit intestinal motility.
Discovery
Bombesin was isolated from the skin of the frog Bombina bonmina by Anastasi and team in 19711.
Classification
Bombesin-like peptides are grouped into three families - 1) Bombesin group, viz., bombesin and alytesin, 2) Ranatensin group viz., ranatensins, litorin, and Rohdei litorin, 3) Phyllolitorin group viz., Leu(8)- and Phe(8)-phyllolitorins.
Structural characteristics
Bombesin is a small peptide of 14 amino acids.
Mode of action
The biological activity of bombesin is mediated by binding to specific receptors viz., gastrin releasing peptide receptor (GRPR; called also BB2 receptor), neuromedin B receptor (NMBR; called also BB1 receptor) and bombesin receptor subtype 3 (BRS-3; called also BB3 receptor). Bombesin induce Ca2+ release from intracellular stores2.
Functions
Bombesin and bombesin-like factors show a wide spectrum of biological activities. It regulates the contraction of smooth muscle cells, induction of the secretion of neuropeptides and hormones. It is one of the most powerful substances showing anorexic effects in the hypothalamus. It induces the release of gastrin and cholecystokinin in the intestines and the pancreas. They also posses activities of cytokines.
References
1.Anastasi A, Erspamer V, Bucci M (1971). Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia., 27(2):166-167.
2. Wang JL, Kalyanaraman S, Vivo MD, Gautam N (1996). Bombesin and thrombin affect discrete pools of intracellular calcium through different G-proteins. Biochem J., 320:87-91.
Tuesday, June 16, 2009
BAD Peptides
Definition
BAD is a member of the BCl-2 family of proteins and acts to promote apoptosis by forming heterodimers with the survival proteins BCL-2 and BCLXL, thus preventing them from binding with BAX1.
Discovery
BAD was originally identified in a yeast two hybrid system that was used to screen for BCL-2 interacting proteins1.
Classification
BAD belongs to the BH3 sub-family of proteins that also includes other pro-apoptotic proteins; BH3 BID, BIK, BLK, HRK, BNIP3 and BIML2.
Structural Characteristics
BAD peptides contain a highly conserved alpha-helical BH3 domain through which they form heterodimers with BCL-2 and BCLXL3. The BH3 domain is structurally defined as four-turn amphipathic a-helices, containing the sequence motif: Hy-X-X-X-Hy-X-X-X-Sm-D/E-X-Hy4. This domain is sufficient for pro-apoptotic functions of BAD.
Mode of action
BAD peptides are located on the outer-mitochondrail membrane. Activation of NGF or IL-3 receptors on the mitochondrial membrane mediates the activation of AKT or PKA holoenzyme respectively that result in the phosphorylation of BAD at Ser-136 and 1122,5. Phosphorylated BAD is translocated to the cytosol by phosphoserine binding protein. Following a death signal BAD is dephosporylated and found in association with BCL-XL-BCL-2 in which form BAD can exert its functions6.
Functions
BCL-2 family proteins that includes BAD play a pivotal role in deciding whether a cell will live or die by apoptosis. Pro-apoptotic function of BAD is triggered by growth factor deprivation in the cell that results in its dephosphorylation and activation7. Activated BAD binds to BCL-2-BCL-XL and releases BAK and BAX that initiate apoptosis. Increased BAD protein levels have been found in diseases like myocardial ischemia-reperfusion7. BAD is also implicated in cancer. In mouse models it has been found that decrease in BAD levels leads to malignancy8. Interestingly recent studies have shown that the tumor suppressor protein, p53 binds to BAD in response to DNA damage and in turn BAD triggers apoptosis of such cells thus maintaining cell physiology9.
References
1. Elizabeth Y, Jiping Z, Jennifer J, Boise LH, Craig B, Thompson and Stanley JK, (1995). Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death. Cell, 80, Issue 2, 285-91.
2. Atan G, James M.M, Stanley J.K (1999). BCL-2 family members and the mitochondria in apoptosis. Genes and Development, 13; 1899-1911.
3. Sabine O, Jose-L D, William H, Julia C, Yan W, Gary W, Steve C, Suzanne W, Lawrence CF, and Tilman O (1997). Structural properties of Human BAD. J Biol. Chem., 372, 49, 30866-892.
4. Beth L, Sangita S and Guido K (2008). Bcl-2 family members; Dual regulators of apoptosis and autophagy. Autophagy, 4:5, 600-606.
5. Zha J, Harada H, Yang E, Jockel J, Kormeyer SJ (1996c). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell, 87:619–628.
6. Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ (1997). BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J. Biol. Chem., 272:24101–24104.
7. Åsa BG and Roberta AG (2007). Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol., 292:45-51.
8. Zinkel S, Gross A and Yang E (2006). BCL2 family in DNA damage and cell cycle control. Cell Death and Differentiation, 13, 1351–1359.
9. Peng J, Wenjing D and Mian W (2007). p53 and BAD: Remote strangers become close friends, Cell Research, 17: 283–285.
BAD is a member of the BCl-2 family of proteins and acts to promote apoptosis by forming heterodimers with the survival proteins BCL-2 and BCLXL, thus preventing them from binding with BAX1.
Discovery
BAD was originally identified in a yeast two hybrid system that was used to screen for BCL-2 interacting proteins1.
Classification
BAD belongs to the BH3 sub-family of proteins that also includes other pro-apoptotic proteins; BH3 BID, BIK, BLK, HRK, BNIP3 and BIML2.
Structural Characteristics
BAD peptides contain a highly conserved alpha-helical BH3 domain through which they form heterodimers with BCL-2 and BCLXL3. The BH3 domain is structurally defined as four-turn amphipathic a-helices, containing the sequence motif: Hy-X-X-X-Hy-X-X-X-Sm-D/E-X-Hy4. This domain is sufficient for pro-apoptotic functions of BAD.
Mode of action
BAD peptides are located on the outer-mitochondrail membrane. Activation of NGF or IL-3 receptors on the mitochondrial membrane mediates the activation of AKT or PKA holoenzyme respectively that result in the phosphorylation of BAD at Ser-136 and 1122,5. Phosphorylated BAD is translocated to the cytosol by phosphoserine binding protein. Following a death signal BAD is dephosporylated and found in association with BCL-XL-BCL-2 in which form BAD can exert its functions6.
Functions
BCL-2 family proteins that includes BAD play a pivotal role in deciding whether a cell will live or die by apoptosis. Pro-apoptotic function of BAD is triggered by growth factor deprivation in the cell that results in its dephosphorylation and activation7. Activated BAD binds to BCL-2-BCL-XL and releases BAK and BAX that initiate apoptosis. Increased BAD protein levels have been found in diseases like myocardial ischemia-reperfusion7. BAD is also implicated in cancer. In mouse models it has been found that decrease in BAD levels leads to malignancy8. Interestingly recent studies have shown that the tumor suppressor protein, p53 binds to BAD in response to DNA damage and in turn BAD triggers apoptosis of such cells thus maintaining cell physiology9.
References
1. Elizabeth Y, Jiping Z, Jennifer J, Boise LH, Craig B, Thompson and Stanley JK, (1995). Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death. Cell, 80, Issue 2, 285-91.
2. Atan G, James M.M, Stanley J.K (1999). BCL-2 family members and the mitochondria in apoptosis. Genes and Development, 13; 1899-1911.
3. Sabine O, Jose-L D, William H, Julia C, Yan W, Gary W, Steve C, Suzanne W, Lawrence CF, and Tilman O (1997). Structural properties of Human BAD. J Biol. Chem., 372, 49, 30866-892.
4. Beth L, Sangita S and Guido K (2008). Bcl-2 family members; Dual regulators of apoptosis and autophagy. Autophagy, 4:5, 600-606.
5. Zha J, Harada H, Yang E, Jockel J, Kormeyer SJ (1996c). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell, 87:619–628.
6. Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ (1997). BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J. Biol. Chem., 272:24101–24104.
7. Åsa BG and Roberta AG (2007). Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol., 292:45-51.
8. Zinkel S, Gross A and Yang E (2006). BCL2 family in DNA damage and cell cycle control. Cell Death and Differentiation, 13, 1351–1359.
9. Peng J, Wenjing D and Mian W (2007). p53 and BAD: Remote strangers become close friends, Cell Research, 17: 283–285.
Antimicrobial and Related Peptides
Definition
Antimicrobial peptides (AMPs) are as widespread as bacterial inactivator molecules in the innate immune systems of insects, fungi, plants, and mammals. These peptides are also known as host defense peptides (HDPs) as they have other immuno-modulatory functions besides the direct antimicrobial actions and are even capable of killing cancerous cells 1,2.
Classification
Three broad categories of HDPs have been identified: 1) the linear peptides with helical structures, 2) the cysteine stabilized peptides with beta-sheet, and 3) a group of linear peptides rich in proline and arginine that primarily have been identified in non-mammalian species.
Structural characteristics
In mammals, cathelicidins and defensins are the two principal AMP families. Cathelicidins are peptides with a conserved proregion and a variable C-terminal antimicrobial domain. Defensins are the best-characterized AMPs, they have six invariant cysteines, forming three intramolecular cystine-disulfide bonds.
Mode of action
The mode of action of AMPs elucidated to date include inhibition of cell wall formation, formation of pores in the cell membrane resulting in the disruption of membrane potential with eventual lysis of the cell. These peptides also inhibit nuclease activity of both RNase and DNase.
Functions
They have a broad ability to kill microbes. AMPs form an important means of host defense in eukaryotes. Large AMPs (>100 amino acids), are often lytic, nutrient-binding proteins or specifically target microbial macromolecules. Small AMPs act by disrupting the structure of microbial cell membranes. It plays an active role in wound repair and regulation of the adaptive immune system. They have multiple roles as mediators of inflammation with impact on epithelial and inflammatory cells, influencing diverse processes such as cell proliferation, wound healing, cytokine release, chemotaxis, immune induction 3.
References
1. Gottlieb CT, Thomsen LE, Ingmer H, Mygind PH, Kristensen HH, Gram L(2008). Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression. BMC Microbiol., 8:205.
2. Yeaman MR and Yount NY (2003). Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmocological Reviews, 55(1).
3. Hanna Galkowska H and Olszewski WL (2003). Antimicrobial peptides – their role in immunity and therapeutic potential. Centr Eur J Immunol., 28 (3):138–141.
Antimicrobial peptides (AMPs) are as widespread as bacterial inactivator molecules in the innate immune systems of insects, fungi, plants, and mammals. These peptides are also known as host defense peptides (HDPs) as they have other immuno-modulatory functions besides the direct antimicrobial actions and are even capable of killing cancerous cells 1,2.
Classification
Three broad categories of HDPs have been identified: 1) the linear peptides with helical structures, 2) the cysteine stabilized peptides with beta-sheet, and 3) a group of linear peptides rich in proline and arginine that primarily have been identified in non-mammalian species.
Structural characteristics
In mammals, cathelicidins and defensins are the two principal AMP families. Cathelicidins are peptides with a conserved proregion and a variable C-terminal antimicrobial domain. Defensins are the best-characterized AMPs, they have six invariant cysteines, forming three intramolecular cystine-disulfide bonds.
Mode of action
The mode of action of AMPs elucidated to date include inhibition of cell wall formation, formation of pores in the cell membrane resulting in the disruption of membrane potential with eventual lysis of the cell. These peptides also inhibit nuclease activity of both RNase and DNase.
Functions
They have a broad ability to kill microbes. AMPs form an important means of host defense in eukaryotes. Large AMPs (>100 amino acids), are often lytic, nutrient-binding proteins or specifically target microbial macromolecules. Small AMPs act by disrupting the structure of microbial cell membranes. It plays an active role in wound repair and regulation of the adaptive immune system. They have multiple roles as mediators of inflammation with impact on epithelial and inflammatory cells, influencing diverse processes such as cell proliferation, wound healing, cytokine release, chemotaxis, immune induction 3.
References
1. Gottlieb CT, Thomsen LE, Ingmer H, Mygind PH, Kristensen HH, Gram L(2008). Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression. BMC Microbiol., 8:205.
2. Yeaman MR and Yount NY (2003). Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmocological Reviews, 55(1).
3. Hanna Galkowska H and Olszewski WL (2003). Antimicrobial peptides – their role in immunity and therapeutic potential. Centr Eur J Immunol., 28 (3):138–141.
Subscribe to:
Posts (Atom)